We initially chose four breast cancer cell lines characterised by a diversity of activated signaling pathway and estrogen receptor (ER) expression: MCF-7 and T47D were ER+, SKBr3 was HER2+ and MDA-MB-231 was triple-negative. The gene discussed is ERBB2; the disease is breast carcinoma.